Making clinical decisions based on measurable residual disease improves the outcome in multiple myeloma

  1. Martinez-Lopez, J.
  2. Alonso, R.
  3. Wong, S.W.
  4. Rios, R.
  5. Shah, N.
  6. Ruiz-Heredia, Y.
  7. Sanchez-Pina, J.M.
  8. Sanchez, R.
  9. Bahri, N.
  10. Zamanillo, I.
  11. Poza, M.
  12. Buenache, N.
  13. Encinas, C.
  14. Juarez, L.
  15. Miras, F.
  16. Collado, L.
  17. Barrio, S.
  18. Martin, T.
  19. Cedena, M.T.
  20. Wolf, J.
Aldizkaria:
Journal of Hematology and Oncology

ISSN: 1756-8722

Argitalpen urtea: 2021

Alea: 14

Zenbakia: 1

Mota: Gutuna

DOI: 10.1186/S13045-021-01135-W GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus